1. Home
  2. TK vs JANX Comparison

TK vs JANX Comparison

Compare TK & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$13.47

Market Cap

937.1M

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$14.04

Market Cap

847.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
JANX
Founded
1973
2017
Country
Bermuda
United States
Employees
N/A
108
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
937.1M
847.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TK
JANX
Price
$13.47
$14.04
Analyst Decision
Buy
Analyst Count
0
13
Target Price
N/A
$47.00
AVG Volume (30 Days)
446.5K
870.0K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
15.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.12
$12.12
52 Week High
$14.38
$35.34

Technical Indicators

Market Signals
Indicator
TK
JANX
Relative Strength Index (RSI) 55.06 43.52
Support Level $12.09 $13.88
Resistance Level $13.76 $14.44
Average True Range (ATR) 0.50 0.55
MACD -0.08 -0.08
Stochastic Oscillator 39.74 37.35

Price Performance

Historical Comparison
TK
JANX

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: